Nagpur: The Maharashtra Food and Drug Administration (FDA) has registered an FIR against the partners of Nagpur-based pharmaceutical firm M/s Skyline Impex, an alleged supplier and others for reportedly supplying suspected spurious drugs to a customer in Sweden using counterfeit labels and fabricated quality certificates.
The case was registered at Jaripatka Police Station following a complaint filed by FDA Drug Inspector Swati Sudhakar Bharde.
Swedish Customer Allegedly Purchased Research Peptides From Nagpur Firm
According to the FIR, Swedish customer Tommy Blomqvist allegedly purchased MOTS-c and other “research peptides” from Skyline Impex through the IndiaMART platform.
Gold Rate
Sept 07 ,2026 - Time 10.30Hrs
A laboratory examination of a sample reportedly found no detectable active substance. The FDA investigation further stated that branding associated with the US-based company Peptide Sciences, USA had allegedly been used on the products.
The US company reportedly confirmed that the labels and artwork found on the products were fake.
Fabricated Certificates and Counterfeit Labels Found
During an FDA inspection on June 25, officials allegedly discovered fabricated Certificates of Analysis (CoAs) and counterfeit product-label artwork stored on the company’s computer systems.
Investigators also reportedly found QR codes printed on the disputed labels. These codes allegedly redirected users to the genuine foreign company’s website, potentially giving the products an appearance of authenticity.
2,000 Vials of Bacteriostatic Water Seized
The FDA also reportedly found around 2,000 vials of Bacteriostatic Water for Injection, marked “For Export Only.”
Samples from two batches were subsequently tested at a government laboratory and were declared Not of Standard Quality. The samples allegedly failed tests relating to bacterial endotoxins, pH and particulate matter.
Nagpur Partner, Punjab Supplier Among Those Booked
Police have booked Yash Sevendra Berry, a Jaripatka resident and partner in Skyline Impex, along with alleged supplier Manhir Singh of Zirakpur, Punjab, the purported manufacturer M/s Dr Glexx Pharmakem, and unidentified persons.
The case has been registered under Sections 318(4), 336(3), 338, 340(2), 276, 277, 278, 61(2) and 3(5) of the Bharatiya Nyaya Sanhita (BNS).
Investigators have also alleged under-invoicing and manipulation of shipping documents in connection with the consignment reportedly sent to Sweden.
FDA Cancels Skyline Impex Drug Licences
Following the investigation, the FDA has cancelled the wholesale drug licences of Skyline Impex.
Police and FDA officials are continuing their investigation into the alleged counterfeit labelling, quality-certification fraud, drug supply and export documentation.
